These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10293676)

  • 1. Recent changes in the use of experimental drugs.
    Gould SJ
    J Health Care Mark; 1989 Jun; 9(2):52-4. PubMed ID: 10293676
    [No Abstract]   [Full Text] [Related]  

  • 2. AIDS drugs in research.
    Hosp Pharm; 1990 Jun; 25(6):572-3, 576. PubMed ID: 10104831
    [No Abstract]   [Full Text] [Related]  

  • 3. Controversial AIDS drug for US market.
    Barinaga M
    Nature; 1988 Apr; 332(6164):475. PubMed ID: 3357506
    [No Abstract]   [Full Text] [Related]  

  • 4. The fast track: federal agencies and the political demand for AIDS drugs.
    Foreman CH
    Brookings Rev; 1991; 9(2):30-7. PubMed ID: 10110828
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental AIDS drugs--worthless?
    Ohio Med; 1988 Oct; 84(10):790. PubMed ID: 3226679
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of AIDS drugs on hospital unclear.
    McBride G
    Mod Healthc; 1988 Jan; 18(5):40-1. PubMed ID: 10285852
    [No Abstract]   [Full Text] [Related]  

  • 7. New drug initiatives announced.
    Ann Pharmacother; 1992 Jun; 26(6):868. PubMed ID: 1611177
    [No Abstract]   [Full Text] [Related]  

  • 8. Desperation drugs. Frustrated AIDs patients are spurring the FDA to relax the rules of the game.
    Begley S; Hager M; Wilson L
    Newsweek; 1989 Aug; 114(6):48-9, 51. PubMed ID: 10293942
    [No Abstract]   [Full Text] [Related]  

  • 9. A faster track for AIDS drugs?
    Kosterlitz J
    Natl J (Wash); 1989 Jul; 21(30):1931. PubMed ID: 10293944
    [No Abstract]   [Full Text] [Related]  

  • 10. Cancer and AIDS groups push for changes in drug approval process.
    Anderson LF
    J Natl Cancer Inst; 1989 Jun; 81(11):829-31. PubMed ID: 2724348
    [No Abstract]   [Full Text] [Related]  

  • 11. Marketing new drugs.
    Porterfield LM
    Adv Clin Care; 1989; 4(5):9-10. PubMed ID: 2789644
    [No Abstract]   [Full Text] [Related]  

  • 12. Whatever happened to expanded access?
    Notes Undergr; 1997; (No 35):2-3. PubMed ID: 11364564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory hierarchies.
    Oldham RK
    Mol Biother; 1988; 1(1):3-6. PubMed ID: 3267370
    [No Abstract]   [Full Text] [Related]  

  • 14. Indian company seeks US approval for generic AIDS drugs.
    Nature; 2004 Aug; 430(7001):716. PubMed ID: 15306779
    [No Abstract]   [Full Text] [Related]  

  • 15. Fast track for AIDS and cancer drugs.
    Gershon D
    Nature; 1990 Aug; 346(6286):685. PubMed ID: 2388690
    [No Abstract]   [Full Text] [Related]  

  • 16. Growing AIDS "graveyard" placed at FDA's doorstep.
    Pollner F
    Med World News; 1988 Nov; 29(21):74-5. PubMed ID: 10290179
    [No Abstract]   [Full Text] [Related]  

  • 17. The fine line between education and marketing.
    Proj Inf Perspect; 1999 Sep; (28):1-3. PubMed ID: 11367352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Happiness reigns in the drug marketplace.
    Kuller K
    GMHC Treat Issues; 1997; 11(4/5):6-8. PubMed ID: 11364376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug marketing exclusivity under United States and European Union law.
    Junod V
    Food Drug Law J; 2004; 59(4):479-518. PubMed ID: 15875347
    [No Abstract]   [Full Text] [Related]  

  • 20. AIDS and the politics of drug lag.
    Vogel D
    Public Interest; 1989; (96):73-85. PubMed ID: 10294053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.